CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 64 filers reported holding CIDARA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,507 | -13.9% | 1,599,673 | +3.2% | 0.00% | 0.0% |
| Q2 2023 | $1,751 | +9.7% | 1,549,573 | +23.3% | 0.00% | +50.0% |
| Q1 2023 | $1,596 | +78.1% | 1,256,773 | +6.0% | 0.00% | +100.0% |
| Q4 2022 | $896 | -99.9% | 1,185,373 | -8.3% | 0.00% | 0.0% |
| Q3 2022 | $812,000 | +43.7% | 1,293,273 | +11.8% | 0.00% | 0.0% |
| Q2 2022 | $565,000 | -52.8% | 1,156,257 | -19.6% | 0.00% | 0.0% |
| Q1 2022 | $1,197,000 | -33.4% | 1,437,845 | +1.7% | 0.00% | -50.0% |
| Q4 2021 | $1,796,000 | -28.4% | 1,414,257 | +26.2% | 0.00% | -33.3% |
| Q3 2021 | $2,509,000 | +18.7% | 1,120,261 | +7.1% | 0.00% | 0.0% |
| Q2 2021 | $2,114,000 | -1.7% | 1,046,303 | +29.4% | 0.00% | 0.0% |
| Q1 2021 | $2,151,000 | -31.0% | 808,503 | -48.2% | 0.00% | 0.0% |
| Q4 2020 | $3,119,000 | -12.8% | 1,559,654 | +24.3% | 0.00% | -25.0% |
| Q3 2020 | $3,576,000 | -15.7% | 1,254,700 | +9.1% | 0.00% | 0.0% |
| Q2 2020 | $4,242,000 | +82.8% | 1,149,538 | +22.9% | 0.00% | +100.0% |
| Q1 2020 | $2,320,000 | -24.1% | 935,599 | +17.6% | 0.00% | 0.0% |
| Q4 2019 | $3,055,000 | +126.6% | 795,658 | +17.8% | 0.00% | +100.0% |
| Q3 2019 | $1,348,000 | +31.4% | 675,688 | +10.6% | 0.00% | 0.0% |
| Q2 2019 | $1,026,000 | -2.4% | 610,742 | +53.9% | 0.00% | 0.0% |
| Q1 2019 | $1,051,000 | +41.3% | 396,732 | +25.3% | 0.00% | 0.0% |
| Q4 2018 | $744,000 | -45.4% | 316,500 | +2.2% | 0.00% | 0.0% |
| Q3 2018 | $1,363,000 | -46.1% | 309,700 | -43.4% | 0.00% | 0.0% |
| Q2 2018 | $2,531,000 | +141.7% | 547,000 | +109.0% | 0.00% | 0.0% |
| Q1 2018 | $1,047,000 | -14.1% | 261,700 | +46.0% | 0.00% | 0.0% |
| Q4 2017 | $1,219,000 | +5.9% | 179,300 | +26.2% | 0.00% | 0.0% |
| Q3 2017 | $1,151,000 | +13.3% | 142,103 | +4.9% | 0.00% | 0.0% |
| Q2 2017 | $1,016,000 | +266.8% | 135,500 | +281.7% | 0.00% | – |
| Q1 2017 | $277,000 | -46.6% | 35,500 | -28.9% | 0.00% | -100.0% |
| Q4 2016 | $519,000 | +4.2% | 49,900 | +14.7% | 0.00% | 0.0% |
| Q3 2016 | $498,000 | +80.4% | 43,500 | +62.3% | 0.00% | 0.0% |
| Q2 2016 | $276,000 | – | 26,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,627,670 | $1,533,591 | 1.88% |
| 5AM Venture Management, LLC | 1,134,511 | $1,068,936 | 0.31% |
| Nantahala Capital Management | 2,538,406 | $2,391,686 | 0.20% |
| BVF INC/IL | 6,861,127 | $6,464,554 | 0.17% |
| Monashee Investment Management LLC | 369,099 | $347,765 | 0.14% |
| West Family Investments, Inc. | 368,910 | $347,587 | 0.12% |
| JEPPSON WEALTH MANAGEMENT, LLC | 137,560 | $129,609 | 0.06% |
| XTX Topco Ltd | 202,758 | $191,039 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 136,974 | $129 | 0.01% |
| Callan Capital, LLC | 103,462 | $97,482 | 0.01% |